机构：[1]Department of Nephrology, The First Afliated Hospital of Kunming Medical University, No. 295, Xichang Road, Kunming 650032, Yunnan, China[2]Institute for Integrative Genome Biology, University of California Riverside, Riverside, CA 92521, USA[3]Kunming Medical University, Kunming 650500, Yunnan, China[4]Department of Nephrology, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China.四川大学华西医院
National Natural Science Foundation of China (Project Number: 82160142)
and Yunnan Health Technical Training Project of High-level Talents (Project
Number: D-2018027 and D-2019015)
语种：
外文
被引次数：
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2022]版：
大类|2 区医学
小类|3 区生化与分子生物学3 区细胞生物学3 区医学：研究与实验
最新[2023]版：
大类|2 区医学
小类|2 区生化与分子生物学2 区细胞生物学2 区医学：研究与实验
JCR分区：
出版当年[2021]版：
Q1BIOCHEMISTRY & MOLECULAR BIOLOGYQ2CELL BIOLOGYQ2MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版：
Q1CELL BIOLOGYQ1BIOCHEMISTRY & MOLECULAR BIOLOGYQ1MEDICINE, RESEARCH & EXPERIMENTALQ2CELL BIOLOGY
第一作者机构：[1]Department of Nephrology, The First Afliated Hospital of Kunming Medical University, No. 295, Xichang Road, Kunming 650032, Yunnan, China
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Li ChangYan,Ma JingYuan,Mali Niroj,et al.Relevance of the pyroptosis-related inflammasome drug targets in the Chuanxiong to improve diabetic nephropathy[J].MOLECULAR MEDICINE.2022,28(1):doi:10.1186/s10020-022-00567-5.
APA：
Li ChangYan,Ma JingYuan,Mali Niroj,Zhang Le,Wei Tao...&Yang Jing.(2022).Relevance of the pyroptosis-related inflammasome drug targets in the Chuanxiong to improve diabetic nephropathy.MOLECULAR MEDICINE,28,(1)
MLA：
Li ChangYan,et al."Relevance of the pyroptosis-related inflammasome drug targets in the Chuanxiong to improve diabetic nephropathy".MOLECULAR MEDICINE 28..1(2022)
